Journal Information

Statistics

Follow this link to access the full text of the article

437
ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (IKEMA): INTERIM ANALYSIS OF A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY
A. Maiolinoa, P. Moreaub, M. Dimopoulosc, J. Mikhaeld, K. Yonge, M. Capraf, T. Facong, R. Hajekh, I. Spickai, M. Rissej, G. Assetk, S. Macél, T. Martinm
a Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil
b University Hospital Hôtel-Dieu, Nantes, France
c The National and Kapodistrian University of Athens, Athens, Greece
d Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, United States
e University College Hospital, London, United Kingdom
f Hospital Mãe de Deus, Porto Alegre, RS, Brazil
g Lille University Hospital, Lille, France
h University Hospital Ostrava, Ostrava, Czech Republic
i Charles University in Prague, Prague, Czech Republic
j Sanofi R&D, Vitry/Alfortville, France
k Sanofi R&D, Chilly-Mazarin, France
l Sanofi R&D, Vitry/Alfortville, France
m University of California at San Francisco, San Francisco, United States
Read
1052
Times
was read the article
485
Total PDF
396
Total HTML
171
Total EPUB
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Epub Total
2022 June 11 16 6 33
2022 May 17 18 2 37
2022 April 9 23 8 40
2022 March 17 17 3 37
2022 February 18 21 3 42
2022 January 15 15 4 34
2021 December 12 25 4 41
2021 November 16 20 10 46
2021 October 26 53 11 90
2021 September 18 28 4 50
2021 August 27 39 26 92
2021 July 24 25 6 55
2021 June 20 31 4 55
2021 May 25 34 9 68
2021 April 41 34 10 85
2021 March 27 32 9 68
2021 February 20 19 9 48
2021 January 20 13 3 36
2020 December 14 8 4 26
2020 November 19 14 36 69
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy

Subscribe to our newsletter